|
|
||||||||
From the Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
| Abstract |
|---|
|
|
|---|
is an important cytokine associated with age-related macular degeneration (AMD) and proliferative vitreoretinopathy (PVR). TNF-
activates the extrinsic apoptotic pathway. In many cells, nuclear transcription factor (NF)-
B upregulates antiapoptotic proteins and prevents TNF-
mediated apoptosis. However, retinal pigment epithelial (RPE) cells are resistant to TNF-
induced apoptosis, even after specific NF-
B blockade. Herein, the authors investigated the role of caspase-8 in RPE cell resistance to TNF-
mediated cell death.
METHODS. Caspase-8 mRNA and protein expression were measured in human RPE cells, human lens epithelial cells, human trabecular meshwork (TM) cells, human choroidal endothelial cells, human uveal melanoma cells (OCM-1, 92.1 and MKT-BR), T-98G, OVCAR-3, HCT116, and Jurkat cancer cells by real-time reverse transcription-polymerase chain reaction and Western blot, respectively. RPE cells were coinfected with adenovirus encoding caspase-8 and Cre. RPE and T-98G cells were infected with adenovirus encoding mutant inhibitory (I)-
B and then were treated with media alone or with TNF-
. Cell viability was determined by WST-1 assay, and apoptosis was evaluated with DNA fragmentation assay and M30 assay. Caspase-3, -7, -9 expression and Bid protein expression after caspase-8 overexpression were examined by Western blot.
RESULTS. Human RPE cell caspase-8 mRNA and protein levels were low compared with levels in nonneoplastic ocular cells and cancer cells. Overexpression of caspase-8 significantly decreased cell number, caused caspase-8 and caspase-3 activation, decreased full-length Bid, caspase-9, and caspase-7, and significantly increased DNA fragmentation and M30-positive RPE cells. Without TNF-
treatment, NF-
B blockade had no effect on caspase-8mediated RPE cell death. In the presence of TNF-
, NF-
B blockade slightly but significantly enhanced caspase-8mediated RPE cell death.
CONCLUSIONS. RPE cell caspase-8 protein levels are low compared with levels for other cell types and may be regulated posttranscriptionally. Low caspase-8 levels may protect RPE cells from apoptosis normally and in diseases such as AMD and may promote the survival of abnormal cells in PVR. Introduction of caspase-8 into RPE cells may be a potential strategy to treat PVR.
Many diseases of the retina originate in or affect the retinal pigment epithelium. For example, proliferative vitreoretinopathy (PVR), the principal cause of retinal reattachment surgical failure, is characterized by RPE cell migration, proliferation, and collagen secretion that contributes to membrane formation.1 2 Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss among persons older than 65 years in the Western world.3 4 RPE cell death is an important feature of the advanced forms of this disease.5 6 It is important to understand how RPE cells survive or die in diseases such as PVR and AMD so that effective therapy can be designed. However, the mechanism(s) that maintain RPE cell survival in PVR or that contribute to their demise in advanced forms of AMD are not well understood.
Macrophage-released tumor necrosis factor (TNF)-
is an important cytokine associated with PVR and AMD.7 8 9 TNF-
activates the extrinsic apoptotic pathway and the nuclear transcription factor (NF)-
B survival pathway through TNF receptors.10 In many cells, NF-
B upregulates antiapoptosis proteins and thereby prevents TNF-
mediated apoptosis.10 11 However, we have shown that RPE cells are resistant to TNF-
induced apoptosis, even after specific NF-
B blockade.12
Caspases are a family of cysteine proteases that play important roles in regulating apoptosis. Caspase-8 lies at the apex of an apoptotic cascade and initiates proteolytic activation of downstream caspase family members, resulting in apoptosis.13 14 Previously, we showed that the endogenous caspase-8 inhibitor, cellular Fas-associated death domain (FADD)-like interleukin-1ßconverting enzyme-like inhibitory protein (c-FLIP), is expressed by RPE cells and that protein levels are increased in an NF-
Bdependent manner after TNF-
stimulation.12 15 It is thought that the relative abundance of c-FLIP to caspase-8 determines whether caspase-8 is activated.16 Our data showing that RPE cells do not die, even when NF-
B is inhibited, suggested that an extrinsic apoptotic signaling component maybe functionally reduced. In this report, we hypothesized that low RPE cell caspase-8 levels might explain RPE cell resistance to TNF-
mediated cell death.
| Materials and Methods |
|---|
|
|
|---|
after NF-
B blockade.12 23 Jurkat cells were chosen as a positive control for caspase-8 antibody.
Adenoviral Infection and Stimulation
RPE cells (2 x 105) and T-98G cells (1.5 x 105) were seeded in six-well plates (Corning-Costar Incorporated, Corning, NY). RPE cells (7 x 104) were seeded in eight-well chamber slides (Nalge Nunc International, Naperville, IL), and RPE cells (6 x 103) and T-98G cells (5 x 103) were seeded in 96-well plates (Corning-Costar Inc.). Twenty-four hours later, cells were incubated with fresh medium for an additional 24 hours. RPE cells were infected with adenovirus encoding either ß-galactosidase (LacZ) or caspase-8 (Riken, Tsukuba, Japan; prepared by Gene Therapy Center Virus Vector Core Facility, University of North Carolina [UNC], Chapel Hill, NC) at various multiplicities of infection (MOI) in MEM containing 1% FBS for 1 or 2 hours, and then the virus was removed. Adenovirus encoding caspase-8 was coinfected with adenovirus encoding Cre (used as an on-off switching unit of caspase-8 [Riken, prepared by Gene Therapy Center Virus Vector Core Facility at UNC]) at a 2:1 ratio of MOI. Cre is a site-specific recombinase that can recognize loxP sites and excise the neo gene between the loxP sites so that the promoter and the caspase-8 genes are joined.24 25 The total MOI adenovirus used to infect each cell was kept the same in all experiments by supplementing with the LacZ construct. RPE cells and T-98G cells were then infected overnight with adenovirus encoding either LacZ or mutant inhibitory (I)-
B26 (Gene Therapy Center Virus Vector Core Facility, UNC) in MEM containing 1% FBS and then stimulated with TNF-
(1.1 x 103 U/mL [22 ng/mL]; R&D Systems Inc., Minneapolis, MN) in MEM containing 1% FBS for various times.
Real-Time RT-PCR Analysis
Total RNA was isolated, and real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed, as we have previously described.15 Briefly, duplicate reactions were prepared with 20 µL PCR master mix consisting of 10 µL master mix (iQ SYBR Green Supermix; Bio-Rad, Hercules, CA), 1 µL cDNA template, 1 µL each of caspase-8 primer pair (20 nM; forward, CTGCTGGGGATGGCCACTGTG; reverse, TCGCCTCGAGGACATCGCTCTC), and 7 µL RNase-free water. Reactions were denatured at 95°C for 2 minutes and amplified for 50 cycles at 95°C for 15 seconds, 60°C for 15 seconds, and 72°C for 15 seconds. Real-time quantification of caspase-8 gene was normalized to the threshold cycle (CT) value of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the corresponding cell types, where CT equals the PCR cycle number at which the amount of amplified sample product reached 100 relative fluorescence units (RFUs). Fold difference of caspase-8 mRNA expression, relative to T-98G expression, was calculated by comparing CT (2-
CT). A melting curve for all products was obtained immediately after amplification by increasing temperature in 0.4°C increments from 65° for 85 cycles of 10 seconds each. The experiments were separately repeated three times with similar results.
Cell Extracts and Western Blot
Cell extracts were prepared, and Western blot analysis was performed as previously described.15 For Western blot, membranes were incubated overnight at 4°C with the following antibodies (Cell Signaling Technology, Beverly, MA) diluted in 3% milk: mouse monoclonal antibody directed against caspase-8 (9746, 1:1000), rabbit monoclonal antibody directed against caspase-3 (9665, 1:1000), rabbit polyclonal antibody directed against Bid (2002, 1:1000), caspase-7 (9492, 1:1000), and caspase-9 (9502, 1:1000). The following antibodies diluted in 5% milk were used for stripped membranes: mouse monoclonal antibody directed against cytokeratin 18 (1:1500; Sigma, St. Louis, MO) and GAPDH (1:5000; Chemicon, Temecula, CA). Blots were then washed three times (20 minutes per wash) in Tris-buffered saline containing 0.1% Tween-20 (TBST) and incubated with antimouse or antirabbit IgG conjugated with horseradish peroxidase (1:5000 in 3% milk; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) for 60 minutes at room temperature (RT). Immunoreactive bands were visualized using an enhanced chemiluminescence light (ECL) detection kit (Amersham, Piscataway, NJ).
Protein Extraction from Native Human RPE Cells
Eyes were obtained 26 hours and 9 hours after death, respectively, from donors without any known ocular diseases (donor 1, 65-year-old woman; donor 2, 57-year-old man). After the neural retina was removed, 0.15 mL mammalian protein extraction reagent (Pierce, Rockford, IL) containing protease inhibitor cocktail (Roche, Indianapolis, IN) was added to the eyecup, and the RPE was gently scraped from the Bruch membrane with a rubber policeman.27 Another 0.05 mL extraction reagent was added to rinse the eyecup and then collected. Combined lysates were sonicated, and Western blot analysis was performed as described for cultured RPE cells.
Cell Viability Assay
Colorimetric assay was performed based on the cleavage of the tetrazolium salt WST-1 (4-[3-(4-lodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1.3-benzene disulfonate) by mitochondrial dehydrogenases in viable cells (Roche). After 12 hours of stimulation with TNF-
, the cells were incubated with WST-1 solution (10 µL/well) for 1 hour at 37°C. The plate was read on a spectrophotometer at 440 nm with a reference wavelength at 690 nm.
Immunofluorescence Detection of M30
RPE cell medium was removed, and cells were rinsed twice with phosphate-buffered saline (PBS) fixed with ice-cold 100% methanol for 30 minutes at 20°C, washed with washing buffer (PBS containing 0.1% Tween-20), and incubated with M30 CytoDEATH mouse monoclonal antibody (1:50 in washing buffer containing 1% bovine serum albumin (BSA; Roche) for 1 hour at RT. Cells were washed with washing buffer three times and then incubated with fluorescein isothiocyanate (FITC)conjugated goat antimouse IgG antibody (1:100 in washing buffer; Jackson ImmunoResearch Laboratories, Inc.) for 30 minutes at RT. Cells were washed with washing buffer and then incubated with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma) for 5 minutes. Fluorescence stain was observed with a light microscope and epifluorescence attachment. A masked observer determined the percentage of cells with M30-positive stain out of the total number stained with DAPI.
Detection of DNA Fragmentation
After the cell number was counted by hemocytometer, cells (3 x 105) were harvested by lysis in buffers provided in an enzyme-linked immunosorbent assay (ELISA) kit (Cell Death Detection ELISAplus; Roche). Lysates were cleared by centrifugation, and DNA fragmentation, a late marker of apoptosis, was quantified by ELISA according to the manufacturers instructions.
Statistical Analysis
Data are expressed as the mean ± SD. Students t-test was used to determine whether there were statistically significant differences between treatment groups determined by cell viability assay, M30 assay, and DNA fragmentation assay. P < 0.05 was considered statistically significant. Western blot analysis performed in duplicate, cell viability assays performed in quadruplicate, and M30 assay performed in triplicate were separately repeated three times in three individual experiments with similar results. DNA fragmentation assay in triplicate was separately repeated two times in two individual experiments with similar results. Data shown in Figures 1 to 9 are from representative experiments conducted on RPE cells from a 61-year-old donor. Cell viability assay, M30 assay, DNA fragmentation assay, and Western blot to detect cleaved caspase-8, cleaved caspase-3, and decreased full-length Bid were conducted in quadruplicate, triplicate, and duplicate experiments, respectively. These assays were also performed at least twice in a 7-year-old donor with similar results (not shown).
|
|
| Results |
|---|
|
|
|---|
mediated RPE cell death. To test this hypothesis, we first determined RPE caspase-8 mRNA expression in human RPE cells from 11 different donors and in the ARPE-19 cell line by real-time RT-PCR. Human RPE cells and ARPE-19 cells expressed low steady state caspase-8 mRNA levels compared with HCT116, OVCAR-3, and Jurkat cells (Fig. 1A) . To determine whether low RPE cell caspase-8 levels were unique among ocular cell types, we evaluated caspase-8 mRNA expression in human lens, TM, and uveal melanoma cells (OCM-1, 92.1, and MKT-BR). Interestingly, RPE cell caspase-8 mRNA levels were also generally low compared with these ocular cells (Fig. 1B) , though the disparity was not as great as it was compared with non-ocular cells.
RPE Cell Caspase-8 Protein Levels
We next determined whether low steady state mRNA levels correlated with low RPE cell caspase-8 protein. In initial experiments, we found that human RPE cells from 3 different donors and ARPE-19 cells had very low caspase-8 protein levels compared with T-98G cells, HCT116 cells, OVCAR-3 cells, and Jurkat cells (Fig. 2A) . To confirm this result, we tested cultured human RPE cells from eight other donors and found that all the RPE cells tested expressed very low levels of caspase-8 protein (Fig. 2B) .
|
|
|
treatment, NF-
B blockade had no effect on caspase-8mediated RPE cell death. In the presence of TNF-
, NF-
B inhibition slightly but significantly enhanced caspase-8mediated RPE cell death and markedly enhanced mutant I
B-infected T-98G cell death (Fig. 5) .
|
treated mutant I
B (TNF-AdmI
B)-infected T-98G cells (Fig. 6) . Interestingly, the caspase-3 cleavage pattern in Ad8-infected RPE cells (p17/15) was different from that observed in TNF-AdmI
B-infected T-98G cells (p19/17), and endogenous caspase-3 levels in RPE cells were higher than in T-98G cells (Fig. 6) .
|
|
|
| Discussion |
|---|
|
|
|---|
; cell death was further increased following TNF-
exposure after NF-
B was blocked.
Caspase-8 protein levels are highly cell type specific. RPE cell caspase-8 protein levels were lower than those we observed in nonneoplastic ocular cells such as lens epithelial cells, TM cells, choroidal endothelial cells, and a variety of neoplastic cell lines, including human uveal melanoma cells, T-98G cells, and OVCAR-3 cells. In addition, several different cultured nonneoplastic epithelial cells, including renal tubular epithelial cells,31 human gingival epithelial cells,32 and keratinocytes,33 contain significant amounts of endogenous caspase-8 protein that can be processed to an activated form when TNF receptor family member receptors are ligated. The reason for low endogenous caspase-8 levels in human RPE cells, which precludes caspase-8 activation by TNF-
, and higher caspase-8 levels in other nonneoplastic epithelial cells, which permits caspase-8 activation, is unknown. However, we speculate that the need for long-term survival in normal RPE cells, compared with other epithelial cell types that turn over more rapidly, may help to explain these differences. We further hypothesize that low human RPE cell caspase-8 protein levels in persons of all ages, as observed in the present report, may help RPE cells to survive for the duration of a persons entire life.
Low RPE caspase-8 protein levels observed in the present report could reflect gene silencing or posttranscriptional regulation. Some cells use the former mechanism almost exclusively. For example, the caspase-8 gene CASP8 is frequently inactivated in a variety of cancers, including neuroblastoma, Ewing sarcoma, and malignant brain tumors, and in certain cancer cell lines including small cell lung carcinoma, neuroblastoma, and retinoblastoma cells.34 35 36 37 38 39 40 In these tissues andcells, the gene is silenced through a combination of DNA methylation and allelic deletion.34 35 36 37 38 39 Reexpression of caspase-8 through demethylation of its promoter using 5-aza-2'-deoxycytidine or overexpression with a caspase-8 expression vector increased sensitivity of cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.34 41 42 Although we cannot exclude DNA silencing as a possible mechanism for decreased caspase-8 protein, low levels of caspase-8 transcripts were identified by real-time PCR, which suggests that in RPE cells caspase-8 is, at least in part, posttranscriptionally regulated. Studies to address these possible mechanisms are under way in our laboratory.
RPE cell procaspase-8 was transduced by adenoviral vector infection. However, after transduction, both procaspase-8 and cleaved caspase-8 were observed. It is likely that in human RPE cells, as has been demonstrated in other cell types,24 43 44 45 caspase-8 overexpression leads to caspase-8 self-aggregation and cleavage to active forms without any external apoptotic signal. In contrast, overexpression of caspase-3, a key effector caspase, does not cause caspase-3 self-activation.46 47 48 Resistance to downstream caspase-3 autoactivation, in addition to low caspase-8 levels, may provide additional control to prevent unwanted RPE cell death.
Low levels of endogenous RPE cell caspase-8 protein precluded an analysis of endogenous caspase-8 activity. In most cells with functional caspase-8, TNF-
induces cell death, especially when NF-
B, a transcription factor that upregulates antiapoptotic factors, is blocked. In contrast, TNF-
does not induce RPE cell death, even when NF-
B is inhibited.12 Furthermore, when we introduced exogenous caspase-8 into RPE cells by an adenoviral vector, cell number was decreased dramatically, caspase-8 was self-cleaved, and caspase-3, a downstream effector, was cleaved, suggesting that the introduction of exogenous caspase-8 restores the missing caspase-8 activity in RPE cells. Together, these results strongly support a lack of significant endogenous caspase-8 activity.
The activation of caspase-8 by TNF receptor family members leads to apoptosis by two pathways. In the so-called type 1 cells, the level of activation of procaspase-8 initiated at the death-inducing signaling complex (DISC) is sufficient to cleave procaspase-3 directly.13 14 However, in type 2 cells, less procaspase-8 is activated, and the mitochondrial pathway is required to amplify the weak death signal.13 14 When caspase-8 triggers apoptosis through the mitochondria, small amounts of activated caspase-8 can efficiently cleave t-Bid, which then translocates to mitochondria and induces the release of cytochrome c, leading to the activation of caspase-3 through Apaf1.13 14 49 Endogenous cleaved t-Bid is difficult to identify in some cultured cells. Accordingly, reduced full-length Bid levels have been taken to indicate t-Bid cleavage after TNF receptor engagement.49 50 51 52 53 We observed reduced Bid and pro-caspase-9 after relatively low-dose procaspase-8 gene transduction. These data suggest that the mitochondria amplification loop could be used in caspase-8mediated RPE cell apoptosis.
We have previously reported that the antiapoptotic protein c-FLIP is produced by cultured human RPE cells. It is thought that the relative ratio of c-FLIP level to caspase-8 level determine whether caspase-8 can be activated by extrinsic death-inducing signals.16 Together, our results suggest that low RPE cell caspase-8 levels compared with c-FLIP levels would inhibit TNF-
induced death signaling. However, it remains to be determined whether treatment strategies to increase the relative ratio of caspase-8 to c-FLIP could prove beneficial to induce the apoptosis of actively proliferating RPE cells in PVR, a condition characterized by unwanted RPE cell proliferation, or whether strategies to increase c-FLIP/caspase-8 levels would be advantageous to promote RPE cell survival in advanced AMD. Studies to address these questions are under way in our laboratory.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication November 7, 2006; revised February 7 and 28, 2007; accepted April 25, 2007.
Disclosure: P. Yang, None; J.J. Peairs, None; R. Tano, None; N. Zhang, None; J. Tyrell, None; G.J. Jaffe, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Glenn J. Jaffe, Department of Ophthalmology, Duke University Eye Center, Durham, NC 27710; jaffe001{at}mc.duke.edu.
| References |
|---|
|
|
|---|
B at the crossroads of life and death. Nat Immunol. 2002;3:221227.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
B. J Clin Invest. 2001;107:241246.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
B inhibition on TNF-alpha-induced apoptosis in human RPE cells. Invest Ophthalmol Vis Sci. 2004;45:24382446.
B- dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene. 2002;21:39173924.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
B prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest. 1998;101:802811.[Web of Science][Medline][Order article via Infotrieve]
B-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells. Microbiology. 2006;152:797806.
B activation at the death-inducing signaling complex in human keratinocytes. J Biol Chem. 2004;279:5282452834.
1) death signal. J Biol Chem. 1998;273:43454349.This article has been cited by other articles:
![]() |
P. Yang, J. Tyrrell, I. Han, and G. J. Jaffe Expression and Modulation of RPE Cell Membrane Complement Regulatory Proteins Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3473 - 3481. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hu and B. J. Barnes IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway J. Biol. Chem., January 30, 2009; 284(5): 2767 - 2777. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |